Welcome to our dedicated page for Sigmatron Intl news (Ticker: SGMA), a resource for investors and traders seeking the latest updates and insights on Sigmatron Intl stock.
Sigmatron International (SGMA) provides investors and industry professionals with centralized access to corporate developments and operational updates from this leading electronic manufacturing services provider. Track official announcements spanning financial results, supply chain initiatives, and strategic partnerships across industrial, medical, and consumer electronics markets.
This resource delivers timely updates on SGMA’s global manufacturing operations, including facility expansions, quality certifications, and procurement strategies. Users gain insights into the company’s progress through earnings disclosures, product launch announcements, and leadership updates while maintaining compliance with financial reporting standards.
Key coverage areas include quarterly financial performance, manufacturing capacity updates, and strategic client engagements. The archive also features operational milestones related to Sigmatron’s international facilities and supply chain optimization efforts.
Bookmark this page for streamlined access to verified SGMA news, enabling informed analysis of the company’s position in the competitive EMS sector. Check regularly for updates reflecting Sigmatron’s execution of its global growth strategy across diversified electronics markets.
SigmaTron International (NASDAQ: SGMA) has entered into a merger agreement with Transom Capital Group, where Transom will acquire all outstanding shares of SigmaTron for $3.02 per share in cash, valuing the company at approximately $83 million. The purchase price represents a significant premium of 134% over SGMA's closing price on May 20, 2025, and 136% over its 30-day volume-weighted average price.
The transaction is expected to close in Q3 2025, subject to stockholders tendering shares representing at least a majority of voting power and other customary conditions. Following the merger completion, SigmaTron will become privately held and its shares will be delisted from Nasdaq. The Company's Board of Directors has unanimously approved the merger and recommends stockholders tender their shares.
SigmaTron International (NASDAQ: SGMA) reported its Q3 fiscal 2025 financial results, showing significant changes in performance. Revenue decreased 26% to $71.1 million compared to $95.9 million in the same quarter last year. The company recorded a net income of $3.9 million ($0.63 per share), up from $0.6 million ($0.10 per share) year-over-year, largely due to a $7.2 million gain from a sale/leaseback transaction of their Elk Grove Village facility.
For the nine-month period, revenue fell 21% to $230.6 million, with a net loss of $8.9 million, impacted by debt modification expenses and deferred tax charges. The company reports seeing benefits from cost reduction efforts, posting an operating profit in January 2025. Management indicates that component marketplace conditions are normalizing and expects Q4 revenue to exceed Q3 levels, suggesting a potential bottom in the revenue downturn.
SigmaTron International (NASDAQ: SGMA) reported financial results for Q2 FY2025. Revenue decreased 24% to $74.7 million compared to $98.7 million in the prior year. The company recorded a net loss of $9.5 million, with a loss per share of $1.55. For the six-month period, revenue fell 19% to $159.5 million, with a net loss of $12.8 million.
The quarter included $3.3 million in expenses related to debt modification and financing costs. Despite challenges, the company reported an operating profit in October, showing positive impact from restructuring efforts. SigmaTron completed a sale/leaseback of its Elk Grove Village property, expecting to report a one-time capital gain of approximately $7 million in Q3. Management expects current depressed revenue levels to continue through Q3, but anticipates improved conditions in calendar 2025.
SigmaTron International (NASDAQ: SGMA) reported its Q1 fiscal 2025 results, showing a 14% decrease in revenues to $84.8 million compared to $98.1 million in the same period last year. The company posted a net loss of $3.3 million, or $0.54 per share, compared to a net income of $0.3 million, or $0.04 per share, in Q1 fiscal 2024. Despite the year-over-year decline, revenues increased 4.4% sequentially from Q4 fiscal 2024. CEO Gary R. Fairhead noted ongoing market softness but expressed optimism for increased activity in Q4 calendar 2024. The company is focusing on reducing inventory and working capital requirements, while continuing efforts to de-lever its balance sheet with Lincoln International.
SigmaTron International (NASDAQ: SGMA), an electronic manufacturing services company, has regained compliance with Nasdaq Listing Rule 5250(c)(1). The company received notice from Nasdaq on September 10, 2024, confirming its compliance after filing its Form 10-K for the annual period ended April 30, 2024, on September 3, 2024 (amended on September 6, 2024). This development resolves the previous non-compliance issue raised by Nasdaq on August 16, 2024, due to the delay in filing the Form 10-K. The timely resolution of this matter ensures SigmaTron's continued listing on the Nasdaq stock exchange.
SigmaTron International, Inc. (NASDAQ: SGMA) reported financial results for fiscal 2024. The company experienced a 10% decrease in revenues from continuing operations, dropping to $373.9 million compared to $414.4 million in fiscal 2023. SigmaTron reported a net loss of $2.5 million from continuing operations, a significant decline from the $14.2 million net income in the previous year. The fourth quarter was particularly challenging, with a 25% decrease in revenues and a net loss of $3.4 million. The company attributed these results to an industry-wide slowdown and lingering supply chain issues. Despite the current challenges, SigmaTron's CEO, Gary R. Fairhead, expressed a positive outlook, citing strong backlogs and expectations of rebounding demand.
SigmaTron International (SGMA) has received a delinquency notification from Nasdaq due to the late filing of its Form 10-K for the fiscal year ended April 30, 2024. The company attributes the delay to ongoing negotiations with lenders regarding credit agreement amendments. While this non-compliance with Nasdaq Listing Rule 5250(c)(1) doesn't immediately affect SGMA's listing, the company must submit a compliance plan by October 15, 2024. If accepted, Nasdaq may grant an extension until February 12, 2025 for SGMA to regain compliance. The company is currently working on completing the Form 10-K.
FAQ
What is the current stock price of Sigmatron Intl (SGMA)?
What is the market cap of Sigmatron Intl (SGMA)?
